Simplified Patient Care Strategy in Decreasing Early Death in Patients With Acute Promyelocytic Leukemia
Recruiting in Palo Alto (17 mi)
+293 other locations
Overseen byAnand Jillella
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: ECOG-ACRIN Cancer Research Group
No Placebo Group
Trial Summary
What is the purpose of this trial?This clinical trial studies how well simplified patient care strategy works in decreasing early death in patients with acute promyelocytic leukemia. Implementing simplified acute promyelocytic leukemia guidelines along with support from acute promyelocytic leukemia experts may decrease deaths and improve survival.
Eligibility Criteria
Inclusion Criteria
Positive t(15:17) by fluorescence in situ hybridization (FISH) or conventional karyotype
Positive promyelocytic leukemia/retinoic acid receptor PML/RAR alpha by polymerase chain reaction (PCR)
Patients must accept treatment and supportive care guidelines
+2 more
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Observational (simplified guidelines and support)Experimental Treatment3 Interventions
Patients receive standard of care treatment for APL. Patients? doctors regularly discuss with an APL expert to identify and mange treatment.
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
New Ulm Medical CenterNew Ulm, MN
Mayo Clinic in RochesterRochester, MN
Aurora Cancer Care-Kenosha SouthKenosha, WI
Cancer Care Specialists of Illinois - DecaturDecatur, IL
More Trial Locations
Loading ...
Who Is Running the Clinical Trial?
ECOG-ACRIN Cancer Research GroupLead Sponsor
National Cancer Institute (NCI)Collaborator